The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD
Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patien...
Ausführliche Beschreibung
Autor*in: |
Kornstein, Susan G. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Schlagwörter: |
---|
Umfang: |
7 |
---|
Übergeordnetes Werk: |
Enthalten in: Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis - Heidari, Somaye-Sadat ELSEVIER, 2021, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:193 ; year:2016 ; day:15 ; month:03 ; pages:137-143 ; extent:7 |
Links: |
---|
DOI / URN: |
10.1016/j.jad.2015.12.058 |
---|
Katalog-ID: |
ELV029511100 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV029511100 | ||
003 | DE-627 | ||
005 | 20230623201514.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jad.2015.12.058 |2 doi | |
028 | 5 | 2 | |a GBVA2016004000003.pica |
035 | |a (DE-627)ELV029511100 | ||
035 | |a (ELSEVIER)S0165-0327(15)31062-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 570 |a 540 |q VZ |
100 | 1 | |a Kornstein, Susan G. |e verfasserin |4 aut | |
245 | 1 | 4 | |a The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD |
264 | 1 | |c 2016 | |
300 | |a 7 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. | ||
650 | 7 | |a Antidepressant |2 Elsevier | |
650 | 7 | |a Functional impairment |2 Elsevier | |
650 | 7 | |a Depression symptoms |2 Elsevier | |
650 | 7 | |a Recurrent depression |2 Elsevier | |
650 | 7 | |a Chronic depression |2 Elsevier | |
700 | 1 | |a Gommoll, Carl |4 oth | |
700 | 1 | |a Chen, Changzheng |4 oth | |
700 | 1 | |a Kramer, Kenneth |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Heidari, Somaye-Sadat ELSEVIER |t Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |d 2021 |g Amsterdam [u.a.] |w (DE-627)ELV000041335 |
773 | 1 | 8 | |g volume:193 |g year:2016 |g day:15 |g month:03 |g pages:137-143 |g extent:7 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.jad.2015.12.058 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 193 |j 2016 |b 15 |c 0315 |h 137-143 |g 7 | ||
953 | |2 045F |a 610 |
author_variant |
s g k sg sgk |
---|---|
matchkey_str |
kornsteinsusanggommollcarlchenchangzheng:2016----:hefcsfeoincpaeiautainsihiseioei |
hierarchy_sort_str |
2016 |
publishDate |
2016 |
allfields |
10.1016/j.jad.2015.12.058 doi GBVA2016004000003.pica (DE-627)ELV029511100 (ELSEVIER)S0165-0327(15)31062-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Kornstein, Susan G. verfasserin aut The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression Elsevier Gommoll, Carl oth Chen, Changzheng oth Kramer, Kenneth oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:193 year:2016 day:15 month:03 pages:137-143 extent:7 https://doi.org/10.1016/j.jad.2015.12.058 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 193 2016 15 0315 137-143 7 045F 610 |
spelling |
10.1016/j.jad.2015.12.058 doi GBVA2016004000003.pica (DE-627)ELV029511100 (ELSEVIER)S0165-0327(15)31062-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Kornstein, Susan G. verfasserin aut The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression Elsevier Gommoll, Carl oth Chen, Changzheng oth Kramer, Kenneth oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:193 year:2016 day:15 month:03 pages:137-143 extent:7 https://doi.org/10.1016/j.jad.2015.12.058 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 193 2016 15 0315 137-143 7 045F 610 |
allfields_unstemmed |
10.1016/j.jad.2015.12.058 doi GBVA2016004000003.pica (DE-627)ELV029511100 (ELSEVIER)S0165-0327(15)31062-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Kornstein, Susan G. verfasserin aut The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression Elsevier Gommoll, Carl oth Chen, Changzheng oth Kramer, Kenneth oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:193 year:2016 day:15 month:03 pages:137-143 extent:7 https://doi.org/10.1016/j.jad.2015.12.058 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 193 2016 15 0315 137-143 7 045F 610 |
allfieldsGer |
10.1016/j.jad.2015.12.058 doi GBVA2016004000003.pica (DE-627)ELV029511100 (ELSEVIER)S0165-0327(15)31062-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Kornstein, Susan G. verfasserin aut The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression Elsevier Gommoll, Carl oth Chen, Changzheng oth Kramer, Kenneth oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:193 year:2016 day:15 month:03 pages:137-143 extent:7 https://doi.org/10.1016/j.jad.2015.12.058 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 193 2016 15 0315 137-143 7 045F 610 |
allfieldsSound |
10.1016/j.jad.2015.12.058 doi GBVA2016004000003.pica (DE-627)ELV029511100 (ELSEVIER)S0165-0327(15)31062-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Kornstein, Susan G. verfasserin aut The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression Elsevier Gommoll, Carl oth Chen, Changzheng oth Kramer, Kenneth oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:193 year:2016 day:15 month:03 pages:137-143 extent:7 https://doi.org/10.1016/j.jad.2015.12.058 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 193 2016 15 0315 137-143 7 045F 610 |
language |
English |
source |
Enthalten in Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis Amsterdam [u.a.] volume:193 year:2016 day:15 month:03 pages:137-143 extent:7 |
sourceStr |
Enthalten in Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis Amsterdam [u.a.] volume:193 year:2016 day:15 month:03 pages:137-143 extent:7 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Antidepressant Functional impairment Depression symptoms Recurrent depression Chronic depression |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
authorswithroles_txt_mv |
Kornstein, Susan G. @@aut@@ Gommoll, Carl @@oth@@ Chen, Changzheng @@oth@@ Kramer, Kenneth @@oth@@ |
publishDateDaySort_date |
2016-01-15T00:00:00Z |
hierarchy_top_id |
ELV000041335 |
dewey-sort |
3610 |
id |
ELV029511100 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029511100</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623201514.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jad.2015.12.058</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029511100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0327(15)31062-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kornstein, Susan G.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antidepressant</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Functional impairment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Depression symptoms</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Recurrent depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chronic depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gommoll, Carl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Changzheng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kramer, Kenneth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Heidari, Somaye-Sadat ELSEVIER</subfield><subfield code="t">Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000041335</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:193</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:15</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:137-143</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jad.2015.12.058</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">193</subfield><subfield code="j">2016</subfield><subfield code="b">15</subfield><subfield code="c">0315</subfield><subfield code="h">137-143</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Kornstein, Susan G. |
spellingShingle |
Kornstein, Susan G. ddc 610 ddc 570 Elsevier Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD |
authorStr |
Kornstein, Susan G. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000041335 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 570 540 VZ The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression Elsevier |
topic |
ddc 610 ddc 570 Elsevier Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression |
topic_unstemmed |
ddc 610 ddc 570 Elsevier Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression |
topic_browse |
ddc 610 ddc 570 Elsevier Antidepressant Elsevier Functional impairment Elsevier Depression symptoms Elsevier Recurrent depression Elsevier Chronic depression |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
c g cg c c cc k k kk |
hierarchy_parent_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
hierarchy_parent_id |
ELV000041335 |
dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry |
hierarchy_top_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000041335 |
title |
The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD |
ctrlnum |
(DE-627)ELV029511100 (ELSEVIER)S0165-0327(15)31062-4 |
title_full |
The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD |
author_sort |
Kornstein, Susan G. |
journal |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
journalStr |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
zzz |
container_start_page |
137 |
author_browse |
Kornstein, Susan G. |
container_volume |
193 |
physical |
7 |
class |
610 610 DE-600 570 540 VZ |
format_se |
Elektronische Aufsätze |
author-letter |
Kornstein, Susan G. |
doi_str_mv |
10.1016/j.jad.2015.12.058 |
dewey-full |
610 570 540 |
title_sort |
effects of levomilnacipran er in adult patients with first-episode, highly recurrent, or chronic mdd |
title_auth |
The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD |
abstract |
Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. |
abstractGer |
Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. |
abstract_unstemmed |
Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD |
url |
https://doi.org/10.1016/j.jad.2015.12.058 |
remote_bool |
true |
author2 |
Gommoll, Carl Chen, Changzheng Kramer, Kenneth |
author2Str |
Gommoll, Carl Chen, Changzheng Kramer, Kenneth |
ppnlink |
ELV000041335 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.jad.2015.12.058 |
up_date |
2024-07-06T21:39:17.664Z |
_version_ |
1803867345560535040 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029511100</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623201514.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jad.2015.12.058</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029511100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0327(15)31062-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kornstein, Susan G.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Major depressive disorder (MDD) can be challenging to manage due its variable and episodic nature. Post hoc analyses were conducted on five studies (NCT00969709, NCT01377194, NCT00969150, NCT01034462, EudraCT:2006-002404-34) to evaluate the efficacy of levomilnacipran extended-release (ER) in patients with different MDD episode histories.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antidepressant</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Functional impairment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Depression symptoms</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Recurrent depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chronic depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gommoll, Carl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Changzheng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kramer, Kenneth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Heidari, Somaye-Sadat ELSEVIER</subfield><subfield code="t">Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000041335</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:193</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:15</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:137-143</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jad.2015.12.058</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">193</subfield><subfield code="j">2016</subfield><subfield code="b">15</subfield><subfield code="c">0315</subfield><subfield code="h">137-143</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.4000406 |